CXCR4 Is a Potential Target for Anti-HIV Gene Therapy
The human immunodeficiency virus (HIV) epidemic is a global issue. The estimated number of people with HIV is 39,000,000 to date. Antiviral therapy is the primary approach to treat the infection. However, it does not allow for a complete elimination of the pathogen. The advances in modern gene thera...
Main Authors: | Appolinaria K. Prokopovich, Irina S. Litvinova, Alexandra E. Zubkova, Dmitry V. Yudkin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/2/1187 |
Similar Items
-
Diversity and inter-connections in the CXCR4 chemokine receptor/ligand family: molecular perspectives
by: Lukas ePawig, et al.
Published: (2015-08-01) -
CXCR4 Recognition by L- and D-Peptides Containing the Full-Length V3 Loop of HIV-1 gp120
by: Ruohan Zhu, et al.
Published: (2023-04-01) -
Human Immunodeficiency Virus and Heparan Sulfate: from attachment to entry inhibition
by: Bridgette Janine Connell, et al.
Published: (2013-11-01) -
HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell
by: Gabriel Valentín-Guillama, et al.
Published: (2018-09-01) -
HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions
by: Qianqian Qi, et al.
Published: (2017-01-01)